Optima Health (OPT) Share Price, News & Analysis

Company Overview

Optima Health is the UK’s leading provider of technology enabled corporate health and wellbeing solutions in the occupational health sector. Underpinned by a robust clinical governance framework, the Group leverages its proprietary technology and flexible delivery platform to foster healthy high performance within its clients’ workforces. The Group offers a comprehensive range of flexible and progressive services from statutory driven workplace health surveillance medicals to proactive and preventive interventions, through to workplace health advice and attendance management assessments, and clinically effective rehabilitation programmes and pathways aimed at returning people to work.

Key Stats

• Today's Range: 184 to 187
• 50-Day Range: 161 to 195.07
• 52-Week Range: 139 to 201.95
• Volume: 34,944 shs
• Average Volume: 191,752 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: GBX 220
• Consensus Rating: Buy

OPT Stock Analysis - Frequently Asked Questions

How have OPT shares performed this year?

Optima Health's stock was trading at GBX 144 at the beginning of 2025. Since then, OPT stock has increased by 28.8% and is now trading at GBX 185.50.
View the best growth stocks for 2025 here.

How do I buy shares of Optima Health?

Shares of OPT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: LON:OPT
• CIK: N/A
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: GBX 220
• High Stock Price Target: GBX 220
• Low Stock Price Target: GBX 220
• Potential Upside/Downside: +18.6%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A